Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells

Biomacromolecules

Volumn 13, Issue 4, 2012, Pages 1144-1151

  El Dakdouki, Mohammad H ^a   Zhu, David C ^a   El Boubbou, Kheireddine ^a   Kamat, Medha ^a   Chen, Jianjun ^b   Li, Wei ^b   Huang, Xuefei ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELLS; CANCER MONITORING; CELLULAR DISTRIBUTIONS; DOXORUBICIN; ENHANCED UPTAKE; HA COATING; HYALURONAN; RELAXIVITY; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; TARGETED IMAGING; UPTAKE MECHANISM;

CHEMOTHERAPY; DRUG DELIVERY; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; SUPERPARAMAGNETISM;

CELLS;

DOXORUBICIN; HYALURONIC ACID; NANOCOATING; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG POTENCY; DRUG RELEASE; DRUG UPTAKE; HUMAN; HUMAN CELL; MAGNETISM; MULTIDRUG RESISTANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; DIAGNOSTIC IMAGING; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HUMANS; HYALURONIC ACID; MICROSCOPY, CONFOCAL; MOLECULAR STRUCTURE; NANOPARTICLES; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION;

EID: 84860743096     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm300046h     Document Type: Article

References (72)

1. American Cancer Society. Cancer Facts and Figures; American Cancer Society: Atlanta, Georgia, 2010.
2. Gewirtz, D. A.; Bristol, M. L.; Yalowich, J. C. Curr. Opin. Invest. Drugs 2010, 11, 612-614.
3. Perez-Tomas, R. Curr. Med. Chem. 2006, 13, 1859-1876.
4. Gottesman, M. M.; Ling, V. FEBS Lett. 2006, 580, 998-1009.
5. Gottesman, M. M.; Fojo, T.; Bates, S. E. Nat. Rev. Cancer 2002, 2, 48-58.
6. Jaracz, S.; Chen, J.; Kuznetsova, L. V.; Ojima, I. Bioorg. Med. Chem. 2010, 13, 5043-5054.
7. Gao, J.; Gu, H.; Xu, B. Acc. Chem. Res. 2009, 42, 1097-1107.
8. Gindy, M. E.; Prud'homme, R. K. Exp. Opin. Drug Delivery 2009, 6, 865-878.
9. Peng, X.-H.; Qian, X.; Mao, H.; Wang, A. Y.; Chen, Z.; Nie, S.; Shin, D. M. Int. J. Nanomed. 2008, 3, 311-321.
10. El-Boubbou, K.; Zhu, D. C.; Vasileiou, C.; Borhan, B.; Prosperi, D.; Li, W.; Huang, X. J. Am. Chem. Soc. 2010, 132, 4490-4499.
11. El-Boubbou, K.; Gruden, C.; Huang, X. J. Am. Chem. Soc. 2007, 129, 13392-13393.
12. Li, X.; Zhou, H.; Yang, L.; Du, G.; Pai-Panandiker, A. S.; Huang, X.; Yan, B. Biomaterials 2010, 32, 2540-2545 and references cited therein.
13. Zöller, M. Nat. Rev. Cancer 2011, 11, 254-267.
14. Misra, S.; Heldin, P.; Hascall, V. C.; Karamanos, N. K.; Skandalis, S. S.; Markwald, R. R.; Ghatak, S. FEBS J. 2011, 278, 1429-1443.
15. Sy, M.-S.; Mori, H.; Liu, D. Curr. Opin. Oncol. 1997, 9, 108-112.
16. Sarkar, B.; Dosch, J.; Simeone, D. M. Chem. Rev. 2009, 109, 3200-3208.
17. Platt, V. M.; Szoka, F. C. Jr. Mol. Pharm. 2008, 5, 474-486 and references cited therein.
18. Lapcik, L. Jr.; Lapcik, L.; De Smedt, S.; Demeester, J.; Chabrecek, P. Chem. Rev. 1998, 98, 2663-2684.
19. Tammi, R.; MacCallum, D.; Hascall, V. C.; Pienimäki, J. P.; Hyttinen, M.; Tammi, M. J. Biol. Chem. 1998, 273, 28878-28888.
20. Banerji, S.; Wright, A. J.; Noble, M.; Mahoney, D. J.; Campbell, I. D.; Day, A. J.; Jackson, D. G. Nat. Struct. Mol. Biol. 2007, 14, 234-239.
21. Wolny, P. M.; Banerji, S.; Gounou, C.; Brisson, A. R.; Day, A. J.; Jackson, D. G.; Richter, R. P. J. Biol. Chem. 2010, 285, 30170-30180.
22. Lesley, J.; Hascall, V. C.; Tammi, M.; Hyman, R. J. Biol. Chem. 2000, 275, 26967-26975.
23. Bartolazzi, A.; Peach, R.; Aruffo, A.; Stamenkovic, I. J. Exp. Med. 1994, 180, 53-66.
24. Krause, D. S.; Lazarides, K.; von Andrian, U. H.; van Etten, R. A. Nat. Med. 2006, 12, 1175-1180.
25. Jin, L.; Hope, K. J.; Zhai, Q.; Smadja-Joffe, F.; Dick, J. E. Nat. Med. 2006, 12, 1167-1174.
26. Charrad, R.-S.; Y., L.; Delpech, B.; Balitrand, N.; Clay, D.; Jasmin, C.; Chomienne, C.; Smadja-Joffe, F. Nat. Med. 1999, 5, 669-676.
27. Verel, I.; Heider, K.-H.; Siegmund, M.; Ostermann, E.; Patzelt, E.; Sproll, M.; Snow, G. B.; Adolf, G. R.; Van Dongen, G. A. M. S. Int. J. Cancer 2002, 99, 396-402.
28. Eikenes, L.; Tari, M.; Tufto, I.; Bruland, O. S.; de Lange Davies, C. Br. J. Cancer 2005, 93, 81-88.
29. Shuster, S.; Frost, G. I.; Csoka, A. B.; Formby, B.; Stern, R. Int. J. Cancer 2002, 102, 192-197.
30. Upadhyay, K. K.; Bhatt, A. N.; Mishra, A. K.; Dwarakanath, B. S.; Jain, S.; Schatz, C.; Le Meins, J.-F.; Farooque, A.; Chandraiah, G.; Jain, A. K.; Misra, A.; Lecommandoux, S. Biomaterials 2010, 31, 2882-2892.
31. Kamat, M.; El-Boubbou, K.; Zhu, D. C.; Lansdell, T.; Lu, X.; Li, W.; Huang, X. Bioconjugate Chem. 2010, 21, 2128-2135.
32. Choi, Y. K.; Chung, H.; Min, K. H.; Yoon, H. Y.; Kim, K.; Park, J. H.; Kwon, I. C.; Jeong, S. Y. Biomaterials 2010, 31, 106-114.
33. Kim, K. S.; Hur, W.; Park, S.-J.; Hong, S. W.; Choi, J. E.; Goh, E. J.; Yoon, S. K.; Hahn, S. K. ACS Nano 2010, 6, 3005-3014.
34. Banzato, A.; Bobisse, S.; Rondina, M.; Renier, D.; Bettella, F.; Esposito, G.; Quintieri, L.; Meléndez-Alafort, L.; Mazzi, U.; Zanovello, P.; Rosato, A. Clin. Cancer Res. 2008, 14, 3598-3606.
35. Lee, H.; Lee, K.; Kim, I. K.; Park, T. G. Biomaterials 2008, 29, 4709-4718.
36. Palmacci, S.; Josephson, L.; Groman, E. V. Synthesis of Polymer-covered Superparamagnetic Oxide Colloids for Magnetic Resonance Contrast Agents or Other Applications. U.S. Patent 9505669, 1995.
37. Bergman, K.; Elvingson, C.; Hilborn, J.; Svensk, G.; Bowden, T. Biomacromolecules 2007, 8, 2190-2195.
38. Kaittanis, C.; Santra, S.; Santiesteban, O. J.; Henderson, T. J.; Perez, J. M. J. Am. Chem. Soc. 2011, 133, 3668-3676.
39. LaConte, L. E. W.; Nitin, N.; Zurkiya, O.; Caruntu, D.; O'Connor, C. J.; Hu, X.; Bao, G. J. Magn. Reson. Imag. 2007, 26, 1634-1641.
40. Gupta, A. K.; Naregalkar, R. R.; Vaidya, V. D.; Gupta, M. Nanomedicine 2007, 2, 23-39.
41. Mellman, I.; Fuchs, R.; Helenius, A. Annu. Rev. Biochem. 1986, 55, 663-700.
42. Wang, F.; Wang, Y.-C.; Dou, S.; Xiong, M.-H.; Sun, T.-M.; Wang, J. ACS Nano 2011, 5, 3679-3692.
43. Kaneko, T.; Willner, D.; Monkovíc, I.; Knipe, J. O.; Braslawsky, G. R.; Greenfield, R. S.; Vyas, D. M. Bioconjugate Chem. 1991, 2, 133-141.
44. Kratz, F.; Beyer, U.; Schumacher, P.; Krueger, M.; Zahn, H.; Roth, T.; Fiebig, H. H.; Unger, C. Bioorg. Med. Chem. Lett. 1997, 7, 617-622.
45. Pouyani, T.; Prestwich, G. D. Bioconjugate Chem. 1994, 5, 339-47.
46. Luo, Y.; Prestwich, G. D. Bioconjugate Chem. 1999, 10, 755-763.
47. Bajorath, J.; Greenfield, B.; Munro, S. B.; Day, A. J.; Aruffo, A. J. Biol. Chem. 1998, 273, 338-343.
48. Maxwell, C. A.; McCarthy, J.; Turley, E. J. Cell Sci. 2005, 121, 925-932.
49. Kievit, F. M.; Wang, F. Y.; Fang, C.; Mok, H.; Wang, K.; Silber, J. R.; Ellenbogen, R. G.; Zhang, M. J. Controlled Release 2011, 152, 76-83.
50. Tokita, Y.; Okamoto, A. Polym. Degrad. Stab. 1995, 48, 269-273.
51. El-Dakdouki, M. H.; El-Boubbou, K.; Zhu, D. C.; Huang, X. RSC Adv. 2011, 1, 1449-1452.
52. Luo, Y.; Bernshaw, N. J.; Lu, Z.-R.; Kopecek, J.; Prestwich, G. D. Pharm. Res. 2002, 19, 396-402.
53. Yan, Y.; Johnston, A. P. R; Dodds, S. J.; Kamphuis, M. M. J.; Ferguson, C.; Parton, R. G.; Nice, E. C.; Heath, J. K.; Caruso, F. ACS Nano 2010, 4, 2928-2936.
54. Lee, S.-M.; Ahn, R. W.; Chen, F.; Fought, A. J.; O'Halloran, T. V.; Cryns, V. L.; Nguyen, S. T. ACS Nano 2010, 9, 4971-4978.
55. Sun, H.; Guo, B.; Li, X.; Cheng, R.; Meng, F.; Liu, H.; Zhong, Z. Biomacromolecules 2010, 11, 848-854.
56. Hu, X.; Liu, S.; Huang, Y.; Chen, X.; Jing, X. Biomacromolecules 2010, 11, 2094-2102.
57. Eliaz, R. E.; Nir, S.; Marty, C.; Szoka, F. C. Jr. Cancer Res. 2004, 64, 711-718.
58. Goren, D.; Horowitz, A. T.; Tzemach, D.; Tarshish, M.; Zalipsky, S.; Gabizon, A. Clin. Cancer Res. 2000, 6, 1949-1957.
59. Peer, D.; Margalit, R. Int. J. Cancer 2004, 108, 780-789.
60. Lopes de Menezes, D. E.; Pilarski, L. M.; Allen, T. M. Cancer Res. 1998, 58, 3320-3330.
61. Sjögren, H. O.; Isaksson, M.; Willner, D.; Hellström, I.; Hellström, K. E.; Trail, P. A. Cancer Res. 1997, 57, 4530-4536.
62. Vingerhoeds, M. H.; Steerenberg, P. A.; Hendriks, J. J.; Dekker, L. C.; Van Hoesel, Q. G.; Crommelin, D. J.; Storm, G. Br. J. Cancer 1996, 74, 1023-1029.
63. Guthi, J. S.; Yang, S.-G.; Huang, G.; Li, S.; Khemtong, C.; Kessinger, C. W.; Peyton, M.; Minna, J. D.; Brown, K. C.; Gao, J. Mol. Pharm. 2010, 7, 32-40.
64. Ryppa, C.; Mann-Steinberg, H.; Fichtner, I.; Weber, H.; Satchi-Fainaro, R.; Biniossek, M. L.; Kratz, F. Bioconjugate Chem. 2008, 19, 1414-1422.
65. For examples of enhanced cytotoxicities by delivered DOX, see: Zou, P.; Yu, Y.; Wang, A.; Zhong, Y.; Welton, A.; Galbán, C.; Wang, S.; Sun, D. Mol. Pharm. 2010, 7, 1974-1985.
66. For other examples of DOX accumulation in nucleus, see: Shuai, X. T.; Ai, H.; Nasongkla, N.; Kim, S.; Gao, J. J. Controlled Release 2004, 98, 415-426.
67. Yang, X.; Grailer, J. J.; Rowland, I. J.; Javadi, A.; Hurley, S. A.; Matson, V. Z.; Steeber, D. A.; Gong, S. ACS Nano 2010, 4, 6805-6817.
68. Bae, Y.; Fukushima, S.; Harada, A.; Kataoka, K. Angew. Chem., Int. Ed. 2003, 42, 4788-4791.
69. Momparier, R. L.; Karon, M.; Siegel, S. E.; Avila, F. Cancer Res. 1976, 36, 2891-5.
70. Kim, S.-Y.; Kim, S.-J.; Kim, B.-J.; Rah, S.-Y.; Chung, S. M.; Im, M.-J.; Kim, U.-H. Exp. Mol. Med. 2006, 38, 535-545.
71. Shadle, S. E.; Bammel, B. P.; Cusack, B. J.; Knighton, R. A.; Olson, S. J.; Mushlin, P. S.; Ison, R. D. O. Biochem. Pharmacol. 2000, 60, 1435-1444.
72. Jin, Y.; Penning, T. M. Annu. Rev. Pharmacol. Toxicol. 2007, 47, 263-292.